8 Hrs
Source:
The Guardian
The Guardian
Ready to play
Ready to play
A new study shows that a coronary sinus reducer (CSR) implant significantly reduces chest pain in 75% of patients with refractory angina. The small device, implanted via minimally invasive surgery, helps redirect blood flow to reduce symptoms in patients who have not benefited from standard treatments. While promising, the treatment remains experimental, and further trials and NHS approval are needed before wider adoption.
Notice: This Is an AI-Generated Summary
Comments (0)